Shown are neutralizing-antibody titers against virus pseudotyped with spike protein from ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bearing the D614G mutation, along with ...

During the coronavirus disease 2019 (Covid-19) pandemic, the emergence of the BA.1, BA.2, and BA.3 sublineages of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 ...

In a recent study posted to bioRxiv*, researchers evaluated how angiotensin-converting enzyme 2 (ACE2) expression in target cells impacts neutralization. Study: Receptor binding domain (RBD) ...

A recent paper, currently available on bioRxiv* preprint server, reveals the potential for a common class of public antibodies to develop broad cross-neutralization against the severe acute ...